PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,102 | -88.6% | 190,124 | -83.7% | 0.08% | -88.5% |
| Q2 2023 | $1,098,820 | -66.3% | 1,167,343 | -65.7% | 0.72% | -73.5% |
| Q1 2023 | $3,263,457 | -29.5% | 3,407,598 | +1.5% | 2.72% | -32.1% |
| Q4 2022 | $4,631,165 | +34.6% | 3,355,917 | +21.9% | 4.00% | +29.0% |
| Q3 2022 | $3,441,000 | +245.8% | 2,752,422 | +553.1% | 3.10% | +266.0% |
| Q2 2022 | $995,000 | +204.3% | 421,410 | +299.4% | 0.85% | +178.9% |
| Q1 2022 | $327,000 | – | 105,504 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $15,375,000 | 15.35% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $3,831,000 | 4.65% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $7,744,000 | 3.82% |
| Frazier Life Sciences Management, L.P. | 5,009,219 | $15,529,000 | 1.32% |
| Deep Track Capital, LP | 3,375,000 | $10,463,000 | 0.67% |
| Orbimed Advisors | 7,331,999 | $22,729,000 | 0.37% |
| Lynx1 Capital Management LP | 105,504 | $327,000 | 0.30% |
| XTX Topco Ltd | 94,309 | $292,000 | 0.13% |
| Woodline Partners LP | 1,913,880 | $5,933,000 | 0.10% |
| GREAT POINT PARTNERS LLC | 113,900 | $353,000 | 0.08% |